Over the past few years, advances in the treatment of skin cancers have improved both overall and progression free survival for patients. However, the sudden and increasing array of immunotherapy and targeted therapy possibilities, and their potential adverse effects, creates complicated questions and considerations for practitioners devising treatment strategies for individuals. In this feature we delve deeper into these advancements to see what oncologists should be focusing on in the year ahead. Keep checking back as we will be adding more exclusive content throughout the month.
Click the links above to discover our most popular exclusive content from the field of hematologic malignancies; features include peer-reviewed journal articles, infographics and video interviews.